Postoperative Photodynamic Therapy Combined with Sonidegib for Recurrent Margin-Positive Nasal Basal Cell Carcinoma: A Case Report
Clinical, Cosmetic and Investigational Dermatology · 2026-11 · Volume 19 · 1-7
DOI: 10.2147/ccid.s652066 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical, Cosmetic and Investigational Dermatology, 2026-11. Verfasst von Cong Zha und 7 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Hospital of Shandong First Medical University, Jinan, Shandong, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dermatology Hospital of Shandong First Medical University, Jinan, Shandong, People's Republic of China.
- Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China.
ORCID-Profile: Cong Zha
Zitieren
APA
Zha, C., Wang, X., Cao, N., Guo, X., Liu, Y., Zhang, Z., Zuo, C., & Zhang, G. (2026). Postoperative Photodynamic Therapy Combined with Sonidegib for Recurrent Margin-Positive Nasal Basal Cell Carcinoma: A Case Report. Clinical, Cosmetic and Investigational Dermatology, Volume 19, 1-7. https://doi.org/10.2147/ccid.s652066
Vancouver
Zha C, Wang X, Cao N, Guo X, Liu Y, Zhang Z, et al. Postoperative Photodynamic Therapy Combined with Sonidegib for Recurrent Margin-Positive Nasal Basal Cell Carcinoma: A Case Report. Clinical, Cosmetic and Investigational Dermatology. 2026;Volume 19:1-7. doi:10.2147/ccid.s652066
BibTeX
@article{Zha2026,
author = {Zha, Cong and Wang, Xueqing and Cao, Nan and Guo, Xuan and Liu, Yongxia and Zhang, Zhiqiang and Zuo, Chaoqi and Zhang, Guangliang},
title = {Postoperative Photodynamic Therapy Combined with Sonidegib for Recurrent Margin-Positive Nasal Basal Cell Carcinoma: A Case Report},
journal = {Clinical, Cosmetic and Investigational Dermatology},
year = {2026},
volume = {Volume 19},
pages = {1--7},
doi = {10.2147/ccid.s652066}
}
EUVIMED